Aug 28, 2023
DELIVER presentations at ESC Congress
The DELIVER team was proud to present at ESC Congress 2023 in Amsterdam, Netherlands. The following analyses were presented:
Effects of Dapagliflozin in Patients with Heart Failure and Deterioration of Kidney Function Below eGFR 25ml/min/1.73m^2 presented by Scott Solomon
Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial presented by Safia Chatur
Influence of background therapy on efficacy of dapagliflozin in patients with heart failure and improved ejection fraction presented by Maria Pabon
Effects of dapagliflozin in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease: an analysis of the DELIVER trial presented by Jawad Haider Butt
Effect of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction treated with beta-blockers: the DELIVER trial presented by Alexander Peikert
Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER presented by Xiaowen Wang